Hei H - Search Results

1

Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity.

Maniakas A, Henderson YC, Hei H, Peng S, Chen Y, Jiang Y, Ji S, Cardenas M, Chiu Y, Bell D, Williams MD, Hofmann MC, Scherer SE, Wheeler DA, Busaidy NL, Dadu R, Wang JR, Cabanillas ME, Zafereo M, Johnson FM, Lai SY. Maniakas A, et al. Among authors: hei h. J Clin Endocrinol Metab. 2021 Oct 21;106(11):e4652-e4665. doi: 10.1210/clinem/dgab453. J Clin Endocrinol Metab. 2021. PMID: 34147031 Free PMC article.

2

Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC.

George JR, Henderson YC, Williams MD, Roberts DB, Hei H, Lai SY, Clayman GL. George JR, et al. Among authors: hei h. J Clin Endocrinol Metab. 2015 Dec;100(12):E1550-9. doi: 10.1210/jc.2015-2690. Epub 2015 Oct 13. J Clin Endocrinol Metab. 2015. PMID: 26461266 Free PMC article.

3

Male patients with papillary thyroid cancer have a higher risk of extranodal extension.

Hei H, Zhou B, Gong W, Zheng C, Qin J. Hei H, et al. Int J Clin Oncol. 2022 Apr;27(4):648-654. doi: 10.1007/s10147-021-02109-1. Epub 2022 Jan 8. Int J Clin Oncol. 2022. PMID: 35000041

4

[Correlation between BRAF^V600E mutation and aggressive biological behavior of papillary thyroid carcinoma].

Zhou B, Hei H, Li YQ, Zhang DY, Wang DQ, Qin JW. Zhou B, et al. Among authors: hei h. Zhonghua Yi Xue Za Zhi. 2023 Apr 11;103(14):1060-1063. doi: 10.3760/cma.j.cn112137-20220729-01657. Zhonghua Yi Xue Za Zhi. 2023. PMID: 37032157 Chinese.

5

Extranodal extension is an independent predictor of extensive nodal metastasis in T1 papillary thyroid cancer.

Hei H, Li Y, Luo Z, Chai X, Zhang H, Zheng C, Zhou B, Gong W, Qin J. Hei H, et al. Langenbecks Arch Surg. 2022 Jun;407(4):1647-1652. doi: 10.1007/s00423-021-02425-0. Epub 2022 Feb 10. Langenbecks Arch Surg. 2022. PMID: 35146548

6

Macroscopic extranodal extension is an independent predictor of lung metastasis in papillary thyroid cancer.

Hei H, Gong W, Zheng C, Zhou B, Qin J. Hei H, et al. Endocrine. 2022 Jun;77(1):73-79. doi: 10.1007/s12020-022-03045-4. Epub 2022 Apr 7. Endocrine. 2022. PMID: 35389141

7

Design of new drugs for medullary thyroid carcinoma.

Li Y, Luo Z, Wang X, Zhang S, Hei H, Qin J. Li Y, et al. Among authors: hei h. Front Oncol. 2022 Dec 5;12:993725. doi: 10.3389/fonc.2022.993725. eCollection 2022. Front Oncol. 2022. PMID: 36544713 Free PMC article.

8

Lymph node ratio as a tool to stratify patients with N1b papillary thyroid cancer.

Luo Z, Hei H, Qin J, Zheng C, Gong W, Zhou B. Luo Z, et al. Among authors: hei h. Langenbecks Arch Surg. 2023 Aug 16;408(1):315. doi: 10.1007/s00423-023-03033-w. Langenbecks Arch Surg. 2023. PMID: 37584830

9

A nomogram predicting contralateral central neck lymph node metastasis for papillary thyroid carcinoma.

Hei H, Song Y, Qin J. Hei H, et al. J Surg Oncol. 2016 Nov;114(6):703-707. doi: 10.1002/jso.24403. Epub 2016 Sep 16. J Surg Oncol. 2016. PMID: 27634154

10

Individual prediction of lateral neck metastasis risk in patients with unifocal papillary thyroid carcinoma.

Hei H, Song Y, Qin J. Hei H, et al. Eur J Surg Oncol. 2019 Jun;45(6):1039-1045. doi: 10.1016/j.ejso.2019.02.016. Epub 2019 Feb 21. Eur J Surg Oncol. 2019. PMID: 30824213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters